A recent study reveals that people who discontinue popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who stop conventional lifestyle plans.
Research printed in a prominent health publication shows that while overweight people can lose a large proportion of their body weight while using the jabs, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"People using such treatments need to be informed of the risk of rapid weight regain when the treatment concludes," stated researcher Dr. Susan Jebb.
That rate of regain means a return to pre-treatment mass within about a year and a half.
Analyzing Treatments
The analysis, which looked at dozens of trials involving over 9,000 of patients, contrasted the effects of the injectable medications with other pills.
Scientists point out that people who lose weight through diet and exercise usually see a slower creep back—approximately 100 grams monthly—after stopping.
Explaining the Rapid Regain
Doctors suggest the way of the drugs accounts for the amplified rebound.
These medications imitate a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Artificially providing the hormone levels several times higher than the body's typical production could lead to the system to produce less of its own natural hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication leads to hunger is uncontrolled, making overeating much more probable."
A Lifelong Condition?
Medical guidelines recommend the injections for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.
Many experts contend that, considering the significant potential of relapse, the treatment is often ongoing.
This view is reinforced by drug manufacturers, who say that the results "emphasize the long-term nature of excess weight," similar to managing diseases like hypertension.
User Experiences
Users who have come off the medication describe a sudden resurgence of appetite.
"It felt as if a switch activating and you're instantly starving," said a patient.
This difficulty is exacerbated if patients have not developed permanent lifestyle or habit changes during therapy.
Widespread Adoption
Survey data indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.
- Use is higher among females than men.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, researchers stress that while these medications are effective agents for shedding pounds, they are not a permanent solution and lasting health benefits relies on combined lifestyle changes.
